Identification of autoantibodies against PsoP27 in synovial fluid derived from psoriatic arthritis and rheumatoid arthritis patients

References

• Verheul MK, Fearon U, Trouw LA, et al. Biomarkers for rheumatoid and psoriatic arthritis. Clin Immunol. 2015;161(1):2–10. doi: 10.1016/j.clim.2015.04.005.
   PubMed Web of Science ®Google Scholar
• Eder L, Gladman DD. Psoriatic arthritis: phenotypic variance and nosology. Curr Rheumatol Rep. 2013;15(3):316. doi: 10.1007/s11926-013-0316-4.
   PubMed Web of Science ®Google Scholar
• Stolwijk C, Boonen A, van Tubergen A, et al. Epidemiology of spondyloarthritis. Rheum Dis Clin North Am. 2012;38(3):441–476. doi: 10.1016/j.rdc.2012.09.003.
   PubMed Web of Science ®Google Scholar
• Mease P. Psoriatic arthritis and spondyloarthritis assessment and management update. Curr Opin Rheumatol. 2013;25(3):287–296. doi: 10.1097/BOR.0b013e32835fd8d5.
   PubMed Web of Science ®Google Scholar
• Haroon M, Winchester R, Giles JT, et al. Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype. Ann Rheum Dis. 2016;75(1):155–162. doi: 10.1136/annrheumdis-2014-205461.
   PubMed Web of Science ®Google Scholar
• McGonagle D, Conaghan PG, Emery P. Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum. 1999;42(6):1080–1086. doi: 10.1002/1529-0131(199906)42:6<1080::AID-ANR2>3.0.CO;2-7.
   PubMedGoogle Scholar
• Iversen OJ, Lysvand H, Slupphaug G. Pso p27, a SERPINB3/B4-derived protein, is most likely a common autoantigen in chronic inflammatory diseases. Clin Immunol. 2017;174:10–17. doi: 10.1016/j.clim.2016.11.006.
   PubMed Web of Science ®Google Scholar
• Iversen OJ, Lysvand H, Jacobsen T, et al. The psoriasis-associated antigen, Pso p27, is expressed by tryptase-positive cells in psoriatic lesions. Arch Dermatol Res. 1995;287(5):503–505. doi: 10.1007/BF00373437.
   PubMed Web of Science ®Google Scholar
• Lysvand H, Hagen L, Klubicka L, et al. Psoriasis pathogenesis – Pso p27 is generated from SCCA1 with chymase. Biochim Biophys Acta. 2014;1842(5):734–738. doi: 10.1016/j.bbadis.2014.02.005.
   PubMed Web of Science ®Google Scholar
• Asbakk K, Bergh K, Iversen OJ. The psoriasis-associated antigen, Pso p27, participates in the formation of complement activating immune-complexes in psoriatic scale. APMIS. 1990;98(2):143–149. doi: 10.1111/j.1699-0463.1990.tb01014.x.
   PubMed Web of Science ®Google Scholar
• Lysvand H, Helland R, Hagen L, et al. Psoriasis pathogenesis – Pso p27 constitutes a compact structure forming large aggregates. Biochem Biophys Rep. 2015;2:132–136. doi: 10.1016/j.bbrep.2015.06.001.
   PubMedGoogle Scholar
• Sivaprasad U, Kinker KG, Ericksen MB, et al. SERPINB3/B4 contributes to early inflammation and barrier dysfunction in an experimental murine model of atopic dermatitis. J Invest Dermatol. 2015;135(1):160–169. doi: 10.1038/jid.2014.353.
   PubMed Web of Science ®Google Scholar
• Kantaputra P, Daroontum T, Chuamanochan M, et al. SERPINB3, adult-onset immunodeficiency, and generalized pustular psoriasis. Genes. 2023;14(2):266. doi: 10.3390/genes14020266.
   PubMed Web of Science ®Google Scholar
• Titapiwatanakun B, Miyahira Y, Mayuzumi N, et al. SCCA2-transfected human keratinocytes show increased secretion of IL-1alpha and IL-6, but not of TNF-alpha. Arch Dermatol Res. 2005;297(6):274–277. doi: 10.1007/s00403-005-0609-1.
   PubMed Web of Science ®Google Scholar
• Iversen OJ, Rødahl E. The major internal protein, p27, of a retrovirus-like particle participates in immune complex formation in psoriasis. Arch Virol. 1985;86(1–2):37–45. doi: 10.1007/BF01314112.
   PubMed Web of Science ®Google Scholar
• Dalaker M, Jacobsen T, Lysvand H. Expression of the psoriasis-associated antigen, Pso p27, is inhibited by cyclosporin A. Acta Derm Venereol. 1999;79(4):281–284.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580–1588. doi: 10.1136/ard.2010.138461.
   PubMed Web of Science ®Google Scholar
• Spengler J, Lugonja B, Ytterberg AJ, et al. Release of active peptidyl arginine deiminases by neutrophils can explain production of extracellular citrullinated autoantigens in rheumatoid arthritis synovial fluid. Arthritis Rheumatol. 2015;67(12):3135–3145. doi: 10.1002/art.39313.
   PubMed Web of Science ®Google Scholar
• Van Steendam K, Tilleman K, Deforce D. The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis. Rheumatology. 2011;50(5):830–837. doi: 10.1093/rheumatology/keq419.
   PubMed Web of Science ®Google Scholar
• Rantapää-Dahlqvist S, de Jong BAW, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48(10):2741–2749. doi: 10.1002/art.11223.
   PubMedGoogle Scholar
• Boman A, Brink M, Lundquist A, et al. Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study. RMD Open. 2019;5(2):e000946. doi: 10.1136/rmdopen-2019-000946.
   PubMed Web of Science ®Google Scholar
• Lundberg K, Nijenhuis S, Vossenaar ER, et al. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther. 2005;7(3):R458–R467. doi: 10.1186/ar1697.
   PubMed Web of Science ®Google Scholar
• van Venrooij WJ, van Beers JJ, Pruijn GJ. Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Ann N Y Acad Sci. 2008;1143(1):268–285. doi: 10.1196/annals.1443.013.
   PubMed Web of Science ®Google Scholar
• Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. 2006;65(7):845–851. doi: 10.1136/ard.2006.051391.
   PubMed Web of Science ®Google Scholar
• Kakumanu P, Sobel ES, Narain S, et al. Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis. J Rheumatol. 2009;36(12):2682–2690. doi: 10.3899/jrheum.090338.
   PubMed Web of Science ®Google Scholar
• Perez-Alamino R, Garcia-Valladares I, Cuchacovich R, et al. Are anti-CCP antibodies in psoriatic arthritis patients a biomarker of erosive disease? Rheumatol Int. 2014;34(9):1211–1216. doi: 10.1007/s00296-014-2956-8.
   PubMed Web of Science ®Google Scholar
• Eker YO, Pamuk ON, Pamuk GE, et al. The frequency of anti-CCP antibodies in patients with rheumatoid arthritis and psoriatic arthritis and their relationship with clinical features and parameters of angiogenesis: a comparative study. Eur J Rheumatol. 2014;1(2):67–71. doi: 10.5152/eurjrheumatol.2014.022.
   PubMedGoogle Scholar
• Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665–2673. doi: 10.1002/art.21972.
   PubMed Web of Science ®Google Scholar
• Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria committee of the American Rheumatism Association. Arthritis Rheum. 1986;29(8):1039–1049. doi: 10.1002/art.1780290816.
   PubMed Web of Science ®Google Scholar
• Iversen OJ, Lysvand H, Bergh K, et al. The N-terminal amino acid sequence of the psoriasis-associated antigen, Pso p27. Arch Dermatol Res. 1995;287(8):761–763. doi: 10.1007/BF01105802.
   PubMed Web of Science ®Google Scholar
• Rødahl E, Iversen OJ. Antigens related to the major internal protein, p27, of a psoriasis associated retrovirus-like particle are expressed in patients with chronic arthritis. Ann Rheum Dis. 1985;44(11):761–765. doi: 10.1136/ard.44.11.761.
   PubMed Web of Science ®Google Scholar
• Chimenti MS, Sunzini F, Fiorucci L, et al. Potential role of cytochrome c and tryptase in psoriasis and psoriatic arthritis pathogenesis: focus on resistance to apoptosis and oxidative stress. Front Immunol. 2018;9:2363. doi: 10.3389/fimmu.2018.02363.
   PubMed Web of Science ®Google Scholar
• Menon B, Gullick NJ, Walter GJ, et al. Interleukin-17 + CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression. Arthritis Rheumatol. 2014;66(5):1272–1281. doi: 10.1002/art.38376.
   PubMed Web of Science ®Google Scholar
• Caspi D, Anouk M, Golan I, et al. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis. Arthritis Rheum. 2006;55(1):53–56. doi: 10.1002/art.21691.
   PubMedGoogle Scholar
• Alenius GM, Berglin E, Rantapää Dahlqvist S. Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation. Ann Rheum Dis. 2006;65(3):398–400. doi: 10.1136/ard.2005.040998.
   PubMed Web of Science ®Google Scholar
• Shibata S, Tada Y, Komine M, et al. Anti-cyclic citrullinated peptide antibodies and IL-23p19 in psoriatic arthritis. J Dermatol Sci. 2009;53(1):34–39. doi: 10.1016/j.jdermsci.2008.06.008.
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532–1535. doi: 10.1126/science.1092385.
   PubMed Web of Science ®Google Scholar
• Baeten D, Kruithof E, De Rycke L, et al. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy. Arthritis Res Ther. 2005;7(2):R359–R369. doi: 10.1186/ar1501.
   PubMed Web of Science ®Google Scholar
• Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med. 2013;5(178):178ra40. doi: 10.1126/scitranslmed.3005580.
   PubMed Web of Science ®Google Scholar